Odoribacter Species Test · Stool

Your gut hosts trillions of bacteria, and a small number of them do outsized work keeping inflammation in check and your gut wall strong. Odoribacter is one of those workhorses. It ferments fiber and amino acids into butyrate and other short-chain fats that your colon cells burn for fuel and that help quiet the immune system.

Its abundance is partly written into your genes, with published heritability estimates suggesting a meaningful portion of the variation between people traces to host genetics. The rest comes down to diet, exercise, water source, medications, and illness. This test shows how well represented Odoribacter is in your stool right now, giving you a window into a microbial pattern researchers increasingly connect with cardiovascular, metabolic, immune, liver, and brain health.

What Odoribacter Does in Your Gut

Odoribacter is a genus in the family Odoribacteraceae, with Odoribacter splanchnicus being the most studied species. It lives mainly in the colon and is classed as an obligate anaerobe, meaning it thrives only in oxygen-poor environments. When Odoribacter ferments dietary fiber and proteins, it produces short-chain fatty acids (small fats like butyrate and acetate that your gut cells use for fuel), along with indole, a compound made from the amino acid tryptophan.

Those metabolites are not just waste. Butyrate is the preferred energy source for the cells lining your colon, helps maintain the gut barrier, and signals through receptors involved in blood pressure regulation and immune tone. Indole-based molecules can cross into the bloodstream and have been linked to brain signaling in studies of kidney disease and dialysis. Odoribacter's influence reaches well beyond the gut itself.

Heart and Vascular Health

A large population study of about 6,900 adults tracked the gut microbiome and atrial fibrillation risk, finding that higher Odoribacter levels were associated with a lower likelihood of developing atrial fibrillation over time. A bidirectional Mendelian randomization analysis (a genetic method that helps tease apart cause from coincidence) supported a protective causal link between Odoribacter abundance and atrial fibrillation risk.

In women with or at risk of HIV, higher Odoribacter splanchnicus was inversely associated with carotid artery plaque burden and inflammatory markers. Evidence in cholesterol is less flattering. Adults with high cholesterol showed higher fecal Odoribacter that correlated with unfavorable lipid profiles, suggesting the relationship depends on the condition being studied.

Metabolic and Liver Health

In a study of children and adolescents with non-alcoholic fatty liver disease (now often called metabolic dysfunction-associated steatotic liver disease), Odoribacter splanchnicus was depleted compared to lean, healthy peers. A comparison between Dutch and South-Asian Surinamese adults found that Odoribacter splanchnicus was enriched in the Dutch group, which also has lower type 2 diabetes prevalence.

The picture flips in advanced liver disease. In a study of 407 adults with cirrhosis, Odoribacter was more abundant in those who also had hepatocellular carcinoma (a type of liver cancer) than in those without cancer. Odoribacter here was part of a pro-inflammatory microbial signature, not a protective one.

Immune and Autoimmune Patterns

A meta-analysis of gut microbiome shifts across autoimmune diseases found Odoribacter consistently depleted, suggesting that losing this bacterium tends to accompany a more reactive immune environment. In a study of stem cell transplant recipients, a genetic variant that favored higher Odoribacter splanchnicus was associated with roughly 50% lower risk of acute graft-versus-host disease, a serious complication where donor immune cells attack the recipient's tissues.

Brain and Cognitive Health

In a Spanish study of 99 adults across healthy aging, mild cognitive impairment, and Alzheimer's disease, Odoribacter splanchnicus progressively declined as cognition worsened. This fits a broader pattern of short-chain fatty acid producing bacteria thinning out in cognitive decline.

The story is more tangled in other settings. Some studies of children with autism spectrum disorder have found Odoribacter elevated, while other analyses found it decreased. In peritoneal dialysis patients and in women living with HIV, higher Odoribacter has been associated with worse cognition, likely because some Odoribacter metabolites, including indole derivatives, can act on the brain in settings where kidney clearance is impaired.

How to Read Conflicting Findings

Odoribacter is not a simple good number or bad number marker. The same bacterium can look protective in one disease and harmful in another because it plays multiple biological roles at once. Its short-chain fatty acid output generally calms inflammation, but its indole-based metabolites can accumulate and cause trouble when the kidneys or liver cannot clear them. Think of Odoribacter as a phenotype indicator rather than a verdict. Your result is one piece of a larger pattern, and its meaning depends on your broader microbiome, inflammation status, kidney and liver function, and overall health context.

Reference Ranges

Odoribacter does not yet have standardized clinical cutpoints. There is no consensus threshold that separates healthy from unhealthy levels, and assay methods differ meaningfully between labs. What one lab reports as relative abundance, another might report in copies per gram of stool using a different sequencing technique. Compare your results within the same lab over time rather than treating any single number as a fixed target.

These tiers are qualitative orientation only. They are not validated cutpoints, and no guideline body recommends clinical decisions based on Odoribacter alone.

Tracking Your Trend

Gut bacteria fluctuate. A longitudinal study using daily stool sampling found that most bacterial genera show substantial day-to-day variation within the same person, often larger than the differences between people. Stool moisture, transit time, diet in the prior 24 to 48 hours, illness, and medications all move the number.

That variability is exactly why trending beats a single reading. A baseline test establishes where you sit. A repeat in 3 to 6 months, after any dietary or lifestyle change, tells you whether your intervention moved the needle. After that, an annual check keeps a record as the science matures and as your own health evolves. If you are actively treating a gut, metabolic, or inflammatory condition, tighter intervals make sense.

Decision Pathway for an Unexpected Result

A surprisingly low Odoribacter result, especially alongside low Faecalibacterium prausnitzii and Akkermansia muciniphila, points toward a depleted short-chain fatty acid producing community. Pair it with a stool calprotectin to check for inflammation and with a short-chain fatty acid panel to see whether butyrate output is also reduced. If inflammation is present and symptoms suggest inflammatory bowel disease, work with a gastroenterologist on confirmatory evaluation.

An unexpectedly high Odoribacter result in someone with cirrhosis, advanced kidney disease, or neurological symptoms is worth discussing with your specialist, since higher levels have been linked to pro-inflammatory patterns in those settings. For most healthy adults, a single abnormal reading without symptoms is a signal to retest, not to panic.

When Results Can Be Misleading

• Recent antibiotics: any antibiotic course in the prior 4 to 8 weeks can sharply reduce Odoribacter along with other anaerobes. Wait at least a month after finishing antibiotics before testing.
• Bowel preparation and colonoscopy: stool collection shortly after a colonoscopy prep reflects a reset community rather than your baseline. Research shows the gut microbiome takes days to repopulate after colonoscopy prep, and diet during that window heavily shapes what grows back.
• Stool moisture and transit time: looser stools and faster transit can shift measured abundances independent of your underlying gut ecology. Collection during a bout of diarrhea will not reflect your typical state.
• Recent acute illness: viral or bacterial gut infections, or any febrile illness, can reshape the microbiome for weeks. Test when you are back to your normal baseline.